Modeling immune system control of atherogenesis

Area of Science:

• Immunology
• Computational Biology
• Cardiovascular Disease Research

Background:

• Atherosclerosis is a widespread disease, often starting in adolescence.
• The roles of oxidized low-density lipoproteins (LDLs) and autoantibodies in human atherosclerosis are not fully understood.
• Computer models offer a virtual environment for studying atherosclerosis progression and treatment efficacy.

Purpose of the Study:

• To develop and apply an agent-based model for simulating atherogenesis.
• To investigate the immune response and plaque progression in a generic artery wall.
• To provide a tool for monitoring disease evolution and quantifying treatment effects.

Main Methods:

• An agent-based model was developed to simulate the immune response to atherogenesis.
• The model incorporates key factors: oxidized LDLs, humoral immune response, autoantibody production, macrophage activity, and foam cell formation.
• The model was validated against available clinical data.

Main Results:

• The model successfully simulated atheromatous plaque progression.
• Simulated levels of oxidized LDLs and immune responses aligned with clinical observations.
• The model reproduced plaque formation in hypercholesterolemic patients.

Conclusions:

• Agent-based modeling is a viable approach for studying atherosclerosis.
• The model provides insights into the interplay of immune responses and lipid metabolism in disease development.
• This computational tool can aid in evaluating therapeutic strategies, including vaccines, for atherosclerosis.